Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Judging by his stout financial backing for Plethora Solutions (PLE), it is probably fair to say that Jim Mellon feels there is an urgent need to find a cure for premature ejaculation. If the market reaction to today’s pump of an RNS is anything to go by, it seems that a lot of private investors agree. The buying frenzy that has happened since Plethora announced its latest ramp leaves me wondering, will people ever learn?
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Monday »
Sunday »
Saturday »
Friday »
Thursday »
Wednesday »
Tuesday »
Time left: 05:51:26